News & events
Minutes Clavis Pharma Annual General Meeting 2013
the Annual General Meeting of Clavis Pharma ASA was held on 17 June 2013. Please find the minutes of the Annual General Meeting attached
Clavis Pharma – Information from the Election Committee
Reference is made to the announcement of 24 May 2013 regarding Clavis Pharma ASA's Annual General Meeting 2013, and agenda item 6 and 8: Remuneration for the Board of Directors and Election of Board members.
Registration to attend the Ordinary General Meeting on 17 June 2013
Please follow the link below to VPS for electronical registration to attend the Extraordinary General Meeting on 17 June 2013 at 14:00 hours at Parkveien 53B, Oslo. The link will be activated on Monday 27 May.
Appointments of Interim Chairman and Acting CEO
Martin Nes, a board member of the Company, as Interim Chairman of the Board of Directors and Gunnar Manum, the CFO of Clavis Pharma, to the additional position of Acting CEO
Changes to the Board of Directors
announces that the Chairman, Anders P. Wiklund, and the board members Annette Clancy and Hilde H. Steineger, have decided to resign from the Board of Directors of Clavis Pharma ASA.
CEO Olav Hellebø to leave Clavis Pharma
Clavis Pharma ASA (OSE: CLAVIS), the Norwegian cancer drug development company, announces that Olav Hellebø will leave the position as CEO of the company effective 20 May by mutual agreement.
Minutes from Extraordinary General Meeting
The Extraordinary General Meeting elected Martin Nes and Øystein Stray Spetalen as new directors.
Clavis Pharma - First Quarter Results 2013
Clavis Pharma ASA (OSE: CLAVIS), the Norwegian cancer drug development company, announces its results for the first quarter 2013, and including significant post-period events.
Recommendation by the Election Committee
Proposal for the extraordinary shareholders meeting May 2nd 2013
Registration to attend the Extraordinary General Meeting on 2 May 2013
Please follow the link below to VPS for electronical registration to attend the Extraordinary General Meeting on 2 May 2013 at 13:00 hours at Parkveien 53B, Oslo.